$12.72+0.18 (+1.44%)
Albertsons Companies, Inc., through its subsidiaries, operates in the food and drug retail industry in the United States.
Albertsons Companies, Inc. in the Consumer Defensive sector is trading at $12.72 with a market capitalization of $5.8B. Wall Street consensus targets $14.19 (16 analysts), implying a +11.5% move over the next 12 months. The stock is currently 36% below its 52-week high of $20.00, remaining 14.8% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 70 is overbought against a weak tape. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $24.94Bβ | $20.25Bβ | $19.12Bβ | $18.92Bβ | $24.88B |
| Gross Profit | $6.64Bβ | $5.51Bβ | $5.25Bβ | $5.11Bβ | $6.74B |
| Operating Income | $258.90Mβ | -$490.20Mβ | $488.50Mβ | $299.70Mβ | $417.40M |
| Net Income | $84.70Mβ | -$480.80Mβ | $293.30Mβ | $168.50Mβ | $236.40M |
Albertsons Companies, Inc., through its subsidiaries, operates in the food and drug retail industry in the United States. The company's food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy...